Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus: From bedside to bench

Bulletin of the NYU Hospital for Joint Diseases

Volumn 66, Issue 3, 2008, Pages 184-187

  Von Feldt, Joan M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; INTERFERON;

AMINO ACID BLOOD LEVEL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CORONARY ARTERY; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; PATHOGENESIS; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGE OF ONSET; ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FOLIC ACID; HOMOCYSTEINE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RUPTURE; UP-REGULATION;

EID: 53649087679     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Vaccarino V, Parsons L, Every NR, et al. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341:217-25.
2. Miller AP, Oparil S. Secondary prevention of coronary heart disease in women: a call to action. Ann Intern Med. 2003 Jan 21;138(2):150-1.
3. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med. 1985;55(216):87-98.
4. Manzi S, Meilahn E, Rairie J, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145(5):408-15.
5. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(1):51-60.
6. Daviglus M, Stamler J, Pirzada A, et al. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA. 2004;292(13):1588-92.
7. Fukumoto S, Tsumagari T, Kinjo M, Tanaka K. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol Jpn. 1987 Jan;37(1):1-9.
8. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med. 1981 Apr;70(4):775-81.
9. Virmani R, Burke AP, Kolodgie FD, Farb A. Pathology of the thin-cap fibroatheroma: a type of vulnerable plaque. J Interv Cardiol. 2003 Jun;16(3):267-72.
10. Aubry MC, Maradit-Kremers H, Reinalda MS, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007 May;34(5):937-42.
11. Doherty TM, Detrano RC, Mautner SL, et al. Coronary calcium: the good, the bad, and the uncertain. Am Heart J. 1999 May;137(5):806-14.
12. Arad Y, Spadaro L, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects. Circulation. 1996;93(11):1951-3.
13. Raggi P, Cooil B, Shaw LJ, et al. Progression of coronary calcium on serial electron beam tomographic scanning is greater in patients with future myocardial infarction. Am J Cardiol. 2003;92(7):827-9.
14. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004 Jan 14;291(2):210-5.
15. Von Feldt J, Scalzi L, Cucchiara A, et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum. 2006;54(7):2220-7.
16. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 Dec 18;349(25):2399-406. Erratum in: N Engl J Med. 2006 Oct 19;355(16):1746.
17. Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003 Dec 18;349(25):2407-15.
18. Brown NS, Nackos E, Morthala S, et al. Monocyte chemoattract protein-1; plasma concentrations and the A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. J Rheumatol. 2007 April;34(4):740-6.
19. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 Aug;54(8):2541-9.
20. Roman MJ, Crow MK, Lockshin MD, et al. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2007 Oct;56(10):3412-9.
21. Summers CM, Nackos E, Hammons AL, et al. Functional polymorphisms in folate metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus patients. J Rheumatol. (In Press).
22. Thompson T, Sutton-Tyrrell K, Wildman RP, et al. Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus. Arthritis Rheum. 2008 Mar;58(3):835-42.
23. Morales M, Qatanani M, Cucchiara A, et al. Resistin levels are elevated and associated with coronary artery calcification in SLE patients compared to age, gender, and race matched controls. Arthritis Rheum. 2007 Sept;56(9):5796.
24. Bultink IE, Turkstra F, Diamant M, et al. Prevalence of and risk factors for the metabolic syndrome in women with systemic lupus erythematosus. Clin Exp Rheumatol. 2008 Jan-Feb;26(1):32-8.
25. El Magadmi M, Ahmad Y, Turkie W, et al. Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus J Rheumatol. 2006 Jan;33(1):50-6.
26. Tepper OM, Galiano RD, Capla JM, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 2002 Nov 26;106(22):2781-6.
27. Denny MF, Thacker S, Mehta H, et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood. 2007 Oct 15;110(8):2907-15.
28. Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003 Mar 17;197(6):711-23.
29. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2610-5.